In CRC, upregulation of lipid metabolic enzymes such as FASN and ACC leads to tumor progression and metastasis through activation of oncogenic pathways including Wnt, PI3K/AKT, AMPK/mTOR. This evidence concerns the gene PIK3CA and neoplasm.